These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 19797440)
1. Rapid improvement in affective information processing after acute administration of reboxetine. Thase ME Am J Psychiatry; 2009 Oct; 166(10):1096-9. PubMed ID: 19797440 [No Abstract] [Full Text] [Related]
3. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression. Montgomery SA; Schatzberg AF J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622 [No Abstract] [Full Text] [Related]
4. The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing? Healy D; Healy H J Affect Disord; 1998 Dec; 51(3):313-22. PubMed ID: 10333985 [TBL] [Abstract][Full Text] [Related]
5. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline]. MMW Fortschr Med; 2004 Jul; 146(27-28):56. PubMed ID: 15526675 [No Abstract] [Full Text] [Related]
8. The need for new and better antidepressants: reboxetine a new option. Dencker SJ Acta Psychiatr Scand Suppl; 2000; 402():6-11. PubMed ID: 10901153 [TBL] [Abstract][Full Text] [Related]
10. The role of norepinephrine in the treatment of depression. J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985 [No Abstract] [Full Text] [Related]
11. Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression. Scates AC; Doraiswamy PM Ann Pharmacother; 2000 Nov; 34(11):1302-12. PubMed ID: 11098346 [TBL] [Abstract][Full Text] [Related]
12. The effects of reboxetine treatment on depression-like behavior, brain neurotrophins, and ERK expression in rats exposed to chronic mild stress. First M; Gil-Ad I; Taler M; Tarasenko I; Novak N; Weizman A J Mol Neurosci; 2013 May; 50(1):88-97. PubMed ID: 22968760 [TBL] [Abstract][Full Text] [Related]
13. Reboxetine: the first selective noradrenaline re-uptake inhibitor. Kasper S; el Giamal N; Hilger E Expert Opin Pharmacother; 2000 May; 1(4):771-82. PubMed ID: 11249515 [TBL] [Abstract][Full Text] [Related]
14. Noradrenaline in basic models of depression. Leonard BE Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S11-6; discussion S71-3. PubMed ID: 9169306 [TBL] [Abstract][Full Text] [Related]
16. Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Harmer CJ; Hill SA; Taylor MJ; Cowen PJ; Goodwin GM Am J Psychiatry; 2003 May; 160(5):990-2. PubMed ID: 12727705 [TBL] [Abstract][Full Text] [Related]
17. Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia. Ferini-Strambi L; Manconi M; Castronovo V; Riva L; Bianchi A J Psychopharmacol; 2004 Sep; 18(3):417-22. PubMed ID: 15358987 [TBL] [Abstract][Full Text] [Related]